Bortezomib Recruiting Phase 2 Trials for Mantle Cell Lymphoma (MCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02840539Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma